Elisabeth Tarkowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Elisabeth Tarkowski has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Kaj Blennow
3 shared publicationsAnders Wallin
2 shared publicationsAnn-Marie Liljeroth
2 shared publicationsLennart Minthon
2 shared publicationsA Tarkowski
Department of Rheumatology, University of Göteborg, Göteborg, Sweden
1 shared publicationA. Tarkowski
Departments of Rheumatology
1 shared publication
Latest Publications
- 1 September 2003
- Published by Elsevier in Neurobiology of Aging
- Vol. 24 (5) , 707-714
Normal pressure hydrocephalus triggers intrathecal production of TNF-α
- 1 September 2003
- Published by Elsevier in Neurobiology of Aging
- Vol. 24 (5) , 707-714
Normal pressure hydrocephalus triggers intrathecal production of TNF-α
- Open Access
- 1 September 2003
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 74 (9) , 1200-1205
Intrathecal inflammation precedes development of Alzheimer's disease
Objectives: To analyse the cerebrospinal fluid (CSF) values of the proinflammatory cytokines, interleukin 1β (IL1β), tumour necrosis factor α (TNFα), GM-CSF, of the anti-inflammatory cytokine TGFβ, of tau protein, a marker for neurodegeneration, and of β amyloid (Aβ), a protein involved in the formation of senile plaques, in prospectively followed up patients with mild cognitive impairment (MCI). Methods: Analyses of CSF levels of TNFα, IL1β, GM-CSF, TGFβ, βa, and tau protein were performed using ELISA in 56 patients with MCI who were followed up prospectively and in 25 age matched, healthy controls. Results: Patients with MCI displayed significantly higher levels of TNFα and tau protein and significantly lower levels of TGFβ and Aβ compared with the healthy controls. After nine months of follow up, 25 patients still displayed MCI while the remaining 31 patients had progressed to Alzheimer’s disease (AD). Only MCI patients who progressed to AD at follow up, showed significantly higher CSF levels of TNFα than controls. In addition, reduced CSF-Aβ42 levels were only found in MCI patients that progressed to AD, further supporting the notion that disturbed metabolism of Aβ is an early finding in AD. Conclusions: These results demonstrate increased production of the proinflammatory cytokine, TNFα and decreased production of the anti-inflammatory cytokine TGFβ in patients with MCI at risk to develop AD, suggesting a propensity towards inflammation in this patient group and indicating that CNS inflammation is a early hallmark in the pathogenesis of AD.
- 1 September 2003
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 74 (9) , 1200-1205
Open AccessIntrathecal inflammation precedes development of Alzheimer's disease
Objectives: To analyse the cerebrospinal fluid (CSF) values of the proinflammatory cytokines, interleukin 1β (IL1β), tumour necrosis factor α (TNFα), GM-CSF, of the anti-inflammatory cytokine TGFβ, of tau protein, a marker for neurodegeneration, and of β amyloid (Aβ), a protein involved in the formation of senile plaques, in prospectively followed up patients with mild cognitive impairment (MCI). Methods: Analyses of CSF levels of TNFα, IL1β, GM-CSF, TGFβ, βa, and tau protein were performed using ELISA in 56 patients with MCI who were followed up prospectively and in 25 age matched, healthy controls. Results: Patients with MCI displayed significantly higher levels of TNFα and tau protein and significantly lower levels of TGFβ and Aβ compared with the healthy controls. After nine months of follow up, 25 patients still displayed MCI while the remaining 31 patients had progressed to Alzheimer’s disease (AD). Only MCI patients who progressed to AD at follow up, showed significantly higher CSF levels of TNFα than controls. In addition, reduced CSF-Aβ42 levels were only found in MCI patients that progressed to AD, further supporting the notion that disturbed metabolism of Aβ is an early finding in AD. Conclusions: These results demonstrate increased production of the proinflammatory cytokine, TNFα and decreased production of the anti-inflammatory cytokine TGFβ in patients with MCI at risk to develop AD, suggesting a propensity towards inflammation in this patient group and indicating that CNS inflammation is a early hallmark in the pathogenesis of AD.
- 1 August 2003
- Published by Elsevier in Brain Research Bulletin
- Vol. 61 (3) , 255-260
Cerebral pattern of pro- and anti-inflammatory cytokines in dementias
- 1 August 2003
- Published by Elsevier in Brain Research Bulletin
- Vol. 61 (3) , 255-260
Cerebral pattern of pro- and anti-inflammatory cytokines in dementias
- 1 March 2003
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 15 (4) , 207-211
Correlation between Intrathecal Sulfatide and TNF-α Levels in Patients with Vascular Dementia
Objectives: Subcortical vascular dementia (SVD) is associated with white matter lesions and demyelination. The aim of the present study was to examine the cerebrospinal fluid (CSF) levels of TNF-α, a proinflammatory cytokine mediating myelin damage, in SVD patients. The intrathecal TNF-α levels were related to the clinical symptoms of dementia, as well as to intrathecal levels of sulfatide, a marker of white matter degradation, and of neurofilament, a marker of neuronal degeneration. Methods: CSF levels of TNF-a, sulfatide and neurofilament were all analyzed by immunoenzymatic procedures in 17 patients with SVD and in 26 healthy controls. Results: The intrathecal concentration of TNF-α was significantly increased in SVD patients compared to healthy controls (p = 0.0001). The intrathecal levels of TNF-α were significantly correlated (r = 0.6, p = 0.02) to the levels of sulfatide, but not to the levels of neurofilament, (r = 0.08, NS). Conclusions: We have demonstrated intrathecal production of TNF-α in SVD patients. The correlation between TNF-a and sulfatide levels in the CSF suggests that this apoptosis-inducing cytokine leads to the death of oligodendrocytes, thereby contributing to white matter degeneration, a hallmark of SVD.
- 1 March 2003
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 15 (4) , 207-211
Correlation between Intrathecal Sulfatide and TNF-α Levels in Patients with Vascular Dementia
Objectives: Subcortical vascular dementia (SVD) is associated with white matter lesions and demyelination. The aim of the present study was to examine the cerebrospinal fluid (CSF) levels of TNF-α, a proinflammatory cytokine mediating myelin damage, in SVD patients. The intrathecal TNF-α levels were related to the clinical symptoms of dementia, as well as to intrathecal levels of sulfatide, a marker of white matter degradation, and of neurofilament, a marker of neuronal degeneration. Methods: CSF levels of TNF-a, sulfatide and neurofilament were all analyzed by immunoenzymatic procedures in 17 patients with SVD and in 26 healthy controls. Results: The intrathecal concentration of TNF-α was significantly increased in SVD patients compared to healthy controls (p = 0.0001). The intrathecal levels of TNF-α were significantly correlated (r = 0.6, p = 0.02) to the levels of sulfatide, but not to the levels of neurofilament, (r = 0.08, NS). Conclusions: We have demonstrated intrathecal production of TNF-α in SVD patients. The correlation between TNF-a and sulfatide levels in the CSF suggests that this apoptosis-inducing cytokine leads to the death of oligodendrocytes, thereby contributing to white matter degeneration, a hallmark of SVD.
- 1 June 2002
- Published by Bentham Science Publishers Ltd. in Current Drug Targets - Inflammation & Allergy
- Vol. 1 (2) , 193-200
Cytokines in Dementias
Knowledge regarding putative inflammatory component(s) participating in Alzheimers disease (AD) and in vascular dementia (VAD) remains scarce. Recently, we have demonstrated the presence of inflammatory components, such as cytokines, in the CSF of demented patients. Although the initial events triggering the neurodegenerative processes in AD versus VAD may be different and thus lead to different neuropathological outcome, they may initiate a similar cascade of cytokine production in response to neuronal injury. The cytokines released in the CNS may in turn, act in a similar manner in both diseases, amplifying certain pathological changes such as amyloidogenesis and amyloid accumulation in the blood vessels, white matter lesions and angiogenesis. This hypothesis is supported by clinical studies demonstrating the presence of white matter infarcts and cerebrovascular pathology in patients with AD as well as the presence of senile plaques in patients with VAD. This review will focus on the production of pro-inflammatory and anti-inflammatory cytokines in dementia, and their putative role for glia cell activation, amyloidogenesis, vascular changes, white matter damage and neurodegeneration.
- 1 June 2002
- Published by Bentham Science Publishers Ltd. in Current Drug Targets - Inflammation & Allergy
- Vol. 1 (2) , 193-200
Cytokines in Dementias
Knowledge regarding putative inflammatory component(s) participating in Alzheimers disease (AD) and in vascular dementia (VAD) remains scarce. Recently, we have demonstrated the presence of inflammatory components, such as cytokines, in the CSF of demented patients. Although the initial events triggering the neurodegenerative processes in AD versus VAD may be different and thus lead to different neuropathological outcome, they may initiate a similar cascade of cytokine production in response to neuronal injury. The cytokines released in the CNS may in turn, act in a similar manner in both diseases, amplifying certain pathological changes such as amyloidogenesis and amyloid accumulation in the blood vessels, white matter lesions and angiogenesis. This hypothesis is supported by clinical studies demonstrating the presence of white matter infarcts and cerebrovascular pathology in patients with AD as well as the presence of senile plaques in patients with VAD. This review will focus on the production of pro-inflammatory and anti-inflammatory cytokines in dementia, and their putative role for glia cell activation, amyloidogenesis, vascular changes, white matter damage and neurodegeneration.
- 1 March 2002
- Published by Elsevier in Neurobiology of Aging
- Vol. 23 (2) , 237-243
Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia
- 1 March 2002
- Published by Elsevier in Neurobiology of Aging
- Vol. 23 (2) , 237-243
Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia
- 20 July 2001
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 12 (5) , 314-317
Decreased Levels of Intrathecal Interleukin 1 Receptor Antagonist in Alzheimer’s Disease
A growing body of evidence points out the potential role of inflammatory mechanisms in the pathophysiology of brain damage in dementia. In previous studies, we have demonstrated intrathecal production of the proinflammatory cytokine tumor necrosis factor (TNF)α in patients with Alzheimer’s disease (AD). The aim of the present study was to investigate the downstream products of TNF-α expression including interleukin (IL)1β and its naturally occurring antagonist IL-1 receptor agonist (ra) in patients with AD. The cytokine levels were related to neuronal damage, as measured by intrathecal τ and β-amyloid concentration and certain clinical features of the disease. Fifty-two patients with AD and 25 healthy controls were analyzed with respect to cerebrospinal fluid (CSF) levels of IL-1β and IL-1ra. CSF IL-1β was neither detectable in CSF of AD nor in control CSF. In contrast, a significantly lower (p < 0.01) number of patients (24 of 49) than of controls (20 of 24) showed detectable levels of IL-1ra in the CSF. The intrathecal levels of IL-1ra were significantly lower in patients with AD than in the controls. Our study demonstrates a decreased production of the anti-inflammatory compound IL-1ra, suggesting a propensity towards inflammation in patients with AD.
- 20 July 2001
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 12 (5) , 314-317
Decreased Levels of Intrathecal Interleukin 1 Receptor Antagonist in Alzheimer’s Disease
A growing body of evidence points out the potential role of inflammatory mechanisms in the pathophysiology of brain damage in dementia. In previous studies, we have demonstrated intrathecal production of the proinflammatory cytokine tumor necrosis factor (TNF)α in patients with Alzheimer’s disease (AD). The aim of the present study was to investigate the downstream products of TNF-α expression including interleukin (IL)1β and its naturally occurring antagonist IL-1 receptor agonist (ra) in patients with AD. The cytokine levels were related to neuronal damage, as measured by intrathecal τ and β-amyloid concentration and certain clinical features of the disease. Fifty-two patients with AD and 25 healthy controls were analyzed with respect to cerebrospinal fluid (CSF) levels of IL-1β and IL-1ra. CSF IL-1β was neither detectable in CSF of AD nor in control CSF. In contrast, a significantly lower (p < 0.01) number of patients (24 of 49) than of controls (20 of 24) showed detectable levels of IL-1ra in the CSF. The intrathecal levels of IL-1ra were significantly lower in patients with AD than in the controls. Our study demonstrates a decreased production of the anti-inflammatory compound IL-1ra, suggesting a propensity towards inflammation in patients with AD.
- 1 March 2001
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 103 (3) , 166-174
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia
A growing body of evidence points out the potential role of inflammatory mechanisms in the pathophysiology of brain damage in dementia. The aim of the present study was to investigate patterns of loc...
- 1 March 2001
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 103 (3) , 166-174
Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia
A growing body of evidence points out the potential role of inflammatory mechanisms in the pathophysiology of brain damage in dementia. The aim of the present study was to investigate patterns of loc...